Shopping Cart 0
Cart Subtotal
USD 0

TRPHARM Ilac Sanayi Tic AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

TRPHARM Ilac Sanayi Tic AS (TRPharm) is a biopharmaceutical company focused on development and commercialization of novel innovative medicines for the treatment of oncology, neurology, inflammatory and rare diseases. The company conducts research and development programs and provide treatments for a healthy lifestyle for suitable patients, healthcare professional, and health related authorities. TRPharm's pipeline products include RPH-001, RPH-104, rituximab biosimilar indicated for the treatment of Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Lymphoma (CLL). The company offers a range of monoclonal antibodies, and biosimilars in the therapeutic areas of virology, inflammatory diseases, oncology, and other rare diseases. It has partnerships with other pharmaceutical companies for production and healthcare service techniques. TRPharm is headquartered in Istanbul, Turkey.

TRPHARM Ilac Sanayi Tic AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

TRPHARM Enters into Distribution Agreement with Kastle Therapeutics 10

TRPharm and Leadiant Biosciences Enter into Distribution Agreement 11

Dr. Reddy's Labs Enters into Agreement with TR-Pharm 12

TR-Pharm Enters into Distribution Agreement with Sigma-Tau Rare Disease 13

Licensing Agreements 14

TRPharm Enters into Licensing Agreement with Foresee Pharma 14

TR-Pharm Enters into Licensing Agreement with CrystalGenomics 15

TR-Pharm Enters into Licensing Agreement with Toyama Chemical 16

Equity Offering 17

R-Pharm Invests USD136 Million in TR-Pharma 17

TRPHARM Ilac Sanayi Tic AS-Key Competitors 18

TRPHARM Ilac Sanayi Tic AS-Key Employees 19

TRPHARM Ilac Sanayi Tic AS-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Key Facts 2

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TRPHARM Ilac Sanayi Tic AS, Deals By Therapy Area, 2012 to YTD 2018 8

TRPHARM Ilac Sanayi Tic AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

TRPHARM Enters into Distribution Agreement with Kastle Therapeutics 10

TRPharm and Leadiant Biosciences Enter into Distribution Agreement 11

Dr. Reddy's Labs Enters into Agreement with TR-Pharm 12

TR-Pharm Enters into Distribution Agreement with Sigma-Tau Rare Disease 13

TRPharm Enters into Licensing Agreement with Foresee Pharma 14

TR-Pharm Enters into Licensing Agreement with CrystalGenomics 15

TR-Pharm Enters into Licensing Agreement with Toyama Chemical 16

R-Pharm Invests USD136 Million in TR-Pharma 17

TRPHARM Ilac Sanayi Tic AS, Key Competitors 18

TRPHARM Ilac Sanayi Tic AS, Key Employees 19

TRPHARM Ilac Sanayi Tic AS, Other Locations 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

TRPHARM Ilac Sanayi Tic AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.